Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside–based low-intensity therapy

Detalles Bibliográficos
Autores principales: Venugopal, Sangeetha, Borthakur, Gautam, Daver, Naval, DiNardo, Courtney D., Pemmaraju, Naveen, Short, Nicholas J., Abbas, Hussein A., Garcia-Manero, Guillermo, Konopleva, Marina, Ravandi, Farhad, Kadia, Tapan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647734/
https://www.ncbi.nlm.nih.gov/pubmed/35201293
http://dx.doi.org/10.1182/bloodadvances.2021006689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647734/
https://www.ncbi.nlm.nih.gov/pubmed/35201293
http://dx.doi.org/10.1182/bloodadvances.2021006689

Ejemplares similares